Beijing Science Sun Pharmaceutical Co Ltd (300485) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Beijing Science Sun Pharmaceutical Co Ltd (300485) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.68 Million ≈ $4.20 Million USD) by net assets (CN¥3.43 Billion ≈ $502.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Beijing Science Sun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Beijing Science Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300485 total liabilities for a breakdown of total debt and financial obligations.

Beijing Science Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Science Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Meili High Technology Co Ltd SHE:300611	0.064x
Eastman Kodak Co NYSE:KODK	0.024x
Rategain Travel Technologies Limited NSE:RATEGAIN	0.027x
HangZhou Radical Energy Saving Technology Co Ltd SHE:300652	0.065x
Boozt AB ST:BOOZT	0.379x
Link Mobility Group Holding ASA OL:LINK	0.122x
Jilin Liyuan Precision Manufacturing Co Ltd SHE:002501	-0.104x
Redtape Limited NSE:REDTAPE	N/A

Annual Cash Flow Conversion Efficiency for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Beijing Science Sun Pharmaceutical Co Lt.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.39 Billion ≈ $495.39 Million	CN¥135.97 Million ≈ $19.90 Million	0.040x	+556.62%
2023-12-31	CN¥3.47 Billion ≈ $507.42 Million	CN¥21.21 Million ≈ $3.10 Million	0.006x	-81.10%
2022-12-31	CN¥3.41 Billion ≈ $499.28 Million	CN¥110.43 Million ≈ $16.16 Million	0.032x	-42.03%
2021-12-31	CN¥3.28 Billion ≈ $480.42 Million	CN¥183.30 Million ≈ $26.82 Million	0.056x	-39.67%
2020-12-31	CN¥2.85 Billion ≈ $417.03 Million	CN¥263.73 Million ≈ $38.59 Million	0.093x	+45.43%
2019-12-31	CN¥2.71 Billion ≈ $396.74 Million	CN¥172.52 Million ≈ $25.25 Million	0.064x	+10.99%
2018-12-31	CN¥2.56 Billion ≈ $373.95 Million	CN¥146.52 Million ≈ $21.44 Million	0.057x	+22.89%
2017-12-31	CN¥2.32 Billion ≈ $339.41 Million	CN¥108.21 Million ≈ $15.83 Million	0.047x	-54.03%
2016-12-31	CN¥2.10 Billion ≈ $307.00 Million	CN¥212.89 Million ≈ $31.15 Million	0.101x	+12.82%
2015-12-31	CN¥1.88 Billion ≈ $275.51 Million	CN¥169.36 Million ≈ $24.78 Million	0.090x	-72.85%
2014-12-31	CN¥646.64 Million ≈ $94.62 Million	CN¥214.23 Million ≈ $31.35 Million	0.331x	-16.90%
2013-12-31	CN¥493.71 Million ≈ $72.25 Million	CN¥196.82 Million ≈ $28.80 Million	0.399x	-5.55%
2012-12-31	CN¥359.96 Million ≈ $52.67 Million	CN¥151.93 Million ≈ $22.23 Million	0.422x	+35.50%
2011-12-31	CN¥247.37 Million ≈ $36.20 Million	CN¥77.06 Million ≈ $11.28 Million	0.312x	--

About Beijing Science Sun Pharmaceutical Co Ltd

SHE:300485 China Drug Manufacturers - Specialty & Generic

Market Cap

$768.97 Million

CN¥5.25 Billion CNY

Market Cap Rank

#10355 Global

#3000 in China

Share Price

CN¥10.91

Change (1 day)

-0.82%

52-Week Range

CN¥8.07 - CN¥16.63

All Time High

CN¥40.48